Patrick Hargutt
Founder at Stanley Capital Partners LLP
Patrick Hargutt active positions
| Companies | Position | Start | End |
|---|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Founder | 2019-12-31 | - |
| Private Equity Investor | 2019-12-31 | - | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Director/Board Member | 2020-08-31 | - |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Director/Board Member | 2022-08-31 | - |
| Stanley Lab, Inc. | Director/Board Member | 2021-02-28 | - |
Career history of Patrick Hargutt
Former positions of Patrick Hargutt
| Companies | Position | Start | End |
|---|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Director/Board Member | - | 2023-06-11 |
| Director of Finance/CFO | - | 2023-06-11 | |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Private Equity Investor | 2017-12-31 | 2019-10-30 |
Training of Patrick Hargutt
| Technische Universität München | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Germany | 2 |
| France | 2 |
Operational
| Director/Board Member | 4 |
| Private Equity Investor | 2 |
| Founder | 1 |
Sectoral
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finance |
| Private companies | 5 |
|---|---|
| Stanley Lab, Inc. | |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
- Stock Market
- Insiders
- Patrick Hargutt
- Experience
